Stifel Transfers Coverage of Ionis Pharmaceuticals (IONS), Maintains Hold
Stifel assumes coverage on Ionis Pharmaceuticals (NASDAQ: IONS) with a Hold rating ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
